Nature Medicine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Nature Medicine
May 16, 2024, 10:23 |
Insight
News and Views from Christine Lovly and Misty Dawn Shields - Nature Medicine
Nature Medicine shared on X: “Refining neoadjuvant immunotherapy for resectable Non- Small Cell Lung Cancer…
May 16, 2024, 09:09 |
Blog
Kohei Shitara: Happy to report biomarkers in DESTINIY GC01 at Nature Medicine
Kohei Shitara, Medical oncologist at National Cancer Center Hospital East, Japan shared a post on X:…
May 2, 2024, 15:25 |
Blog
Tanja Obradovic: Interesting updates will be coming on ASCO 2024
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "ASCO 2024 is almost…
Apr 29, 2024, 22:33 |
Blog
Marleen Kok: Institutional visit by Ulrike Harjes, Senior Editor of Nature Medicine, to The Netherlands Cancer Institute
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X/Twitter: ''Institutional…
Apr 29, 2024, 08:17 |
Insight
Bob Li: It was a privilege to lead the first international clinical trial to crack KRAS
Bob Li, Chief Scientific Officer of MSK Direct at Memorial Sloan Kettering Cancer Center, shared…
Apr 25, 2024, 21:25 |
Insight
Paper summary by Erman Akkus on TORCH
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X: “Deep-learning method…
Apr 25, 2024, 12:10 |
Blog
Myriam Chalabi: Very happy to host Ulrike Harjes from Nature Medicine
Myriam Chalabi: Medical Oncologist and Cancer Immunotherapy Researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Apr 20, 2024, 07:47 |
Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 13, 2024, 12:22 |
Blog
Saheli Sadanand: The potential of Functional Precision Medicine for treatment of Pediatric Cancers
Saheli Sadanand, Deputy Editor of Nature Medicine, shared a post on X: "New Nature Medicine: Excited…
Apr 12, 2024, 17:36 |
Insight
Mark Yarchoan: Multicenter P1/2 trial of a personalized neoantigen vaccine + anti-PD1 in 2L HCC presented at AACR24
Mark Yarchoan, Associate Professor at Johns Hopkins Hospital, shared on X: "Multicenter P1/2 trial of…
1
2
3
All:
26
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube